| Literature DB >> 32420889 |
Camille Vatier1, Isabelle Jéru2, Soraya Fellahi3, Jacqueline Capeau4, Jean-Philippe Bastard5, Corinne Vigouroux6.
Abstract
Leptin and adiponectin are two adipokines currently used as biomarkers for diagnostic orientation and phenotyping in syndromes of lipodystrophy and severe insulin resistance. The level of these biomarkers also has an impact on the therapeutic management of the patients. These aspects, as well as our experience as a reference center, are described in this brief overview.Entities:
Keywords: adiponectin; insulin resistance; leptin; lipodystrophies; metreleptine
Mesh：
Substances：
Year: 2020 PMID： 32420889 DOI： 10.1684/abc.2020.1551
Source DB: PubMed Journal: Ann Biol Clin (Paris) ISSN： 0003-3898 Impact factor: 0.459